Detalhe da pesquisa
1.
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial.
Ann Oncol
; 34(12): 1141-1151, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072514
2.
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study.
Ann Oncol
; 29(1): 154-161, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045554
3.
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.
Ann Oncol
; 28(1): 44-56, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28177431
4.
A pilot study of cabergoline for the treatment of metastatic breast cancer.
Breast Cancer Res Treat
; 165(3): 585-592, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28674764
5.
Elevated incidence of fractures in women with invasive breast cancer.
Osteoporos Int
; 27(2): 499-507, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26294292
6.
Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab.
Ann Oncol
; 24(10): 2492-2500, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23827380
7.
The sequential use of endocrine treatment for advanced breast cancer: where are we?
Ann Oncol
; 23(6): 1378-86, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22317766
8.
U.S. prevalence of endocrine therapy-naïve locally advanced or metastatic breast cancer.
Curr Oncol
; 26(2): e180-e187, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043825
9.
Meta-analysis of selected toxicity endpoints of CDK4/6 inhibitors: Palbociclib and ribociclib.
Breast
; 35: 1-7, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618307
10.
Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis.
Cancer Treat Rev
; 55: 10-15, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28279895
11.
Clinical potential of new antiestrogens.
J Clin Oncol
; 15(2): 840-52, 1997 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9053512
12.
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer.
J Clin Oncol
; 17(3): 880-6, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10071279
13.
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.
J Clin Oncol
; 22(6): 1071-7, 2004 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15020608
14.
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
J Clin Oncol
; 17(10): 3333-55, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10506637
15.
Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.
Clin Cancer Res
; 1(9): 973-9, 1995 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-9816069
16.
Adjuvant therapy of breast cancer.
Minerva Ginecol
; 57(5): 521-36, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16205597
17.
ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
Oncogene
; 34(45): 5626-34, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25684139
18.
Effects of cancer treatment on the reproductive system.
Crit Rev Oncol Hematol
; 8(2): 153-71, 1988.
Artigo
em Inglês
| MEDLINE | ID: mdl-3046766
19.
Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
Eur J Cancer
; 30A(2): 158-61, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-8155389
20.
Recently initiated studies: neoadjuvant treatments in the next century.
Semin Oncol
; 26(1 Suppl 3): 26-9, 1999 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-10203268